| Application no. and date | 20847817.2 (espacenet) (Federated) (European Patent Register), 20200724 | | Patent/reg. no. and date | DK/EP 4005574, 20240703 | | Publication date | 20220601 | | Priority no. and date | ES 201930713, 20190731 | | EP pub. no. and date |
EP 4005574 20220601 | | Effective date | | | Applicant/owner | Universidade de Santiago de Compostela, Edificio EMPRENDIA - Campus Vida
15782 Santiago de Compostela, ES | | Applicant ref. no. | | | Inventor | LABANDEIRA GARCIA, Jose Luis, Edificio EMPRENDIA - Campus Vida
15782 Santiago de Compostela, ES,
LOPEZ LOPEZ, Andrea, Edificio EMPRENDIA - Campus Vida
15782 Santiago de Compostela, ES,
MUÃ`OZ PATIÃ`O, Ana M., Edificio EMPRENDIA - Campus Vida
15782 Santiago de Compostela, ES | | Representative | | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61K 31/4409 (2006.01) , A61K 31/472 (2006.01) , A61K 31/4725 (2006.01) , A61K 31/517 (2006.01) , A61K 31/519 (2006.01) , A61K 31/551 (2006.01) , A61P 25/14 (2006.01) | | Title | PHARMACEUTICAL COMPOSITION FOR USE IN THE PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF L-DOPA-INDUCED DYSKINESIA | | Int. application no. | ES2020070482 | | Int. publication no. | WO2021019116 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
